AU1578695A - Desogestrel-containing transdermal application agent - Google Patents
Desogestrel-containing transdermal application agentInfo
- Publication number
- AU1578695A AU1578695A AU15786/95A AU1578695A AU1578695A AU 1578695 A AU1578695 A AU 1578695A AU 15786/95 A AU15786/95 A AU 15786/95A AU 1578695 A AU1578695 A AU 1578695A AU 1578695 A AU1578695 A AU 1578695A
- Authority
- AU
- Australia
- Prior art keywords
- desogestrel
- application agent
- transdermal application
- containing transdermal
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4405899A DE4405899A1 (en) | 1994-02-18 | 1994-02-18 | Agent for transdermal application containing desogestrel |
DE4405899 | 1994-02-18 | ||
PCT/EP1995/000481 WO1995022321A1 (en) | 1994-02-18 | 1995-02-09 | Desogestrel-containing transdermal application agent |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1578695A true AU1578695A (en) | 1995-09-04 |
Family
ID=6511045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU15786/95A Abandoned AU1578695A (en) | 1994-02-18 | 1995-02-09 | Desogestrel-containing transdermal application agent |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0744943A1 (en) |
JP (1) | JPH09508911A (en) |
KR (1) | KR970701538A (en) |
AU (1) | AU1578695A (en) |
CA (1) | CA2183544A1 (en) |
DE (1) | DE4405899A1 (en) |
HU (1) | HUT74458A (en) |
NO (1) | NO963433L (en) |
NZ (1) | NZ279226A (en) |
WO (1) | WO1995022321A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19600347A1 (en) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Skin-adhering pharmaceutical preparation, in particular TTS for the delivery of 17-beta-estradiol to the human organism |
FR2749586B1 (en) * | 1996-06-11 | 1998-08-07 | Hoechst Marion Roussel Inc | NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS |
DE19629468A1 (en) * | 1996-07-11 | 1998-01-15 | Schering Ag | Transdermal therapeutic systems |
DE19701949A1 (en) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermal therapeutic system |
WO2000040230A2 (en) * | 1999-01-06 | 2000-07-13 | Cedars-Sinai Medical Center | Hormone replacement for breast cancer patients |
DE10019171A1 (en) * | 2000-04-07 | 2001-10-18 | Schering Ag | Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients |
DE102010040299A1 (en) * | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner) |
BRPI1003661A2 (en) * | 2010-09-15 | 2013-01-08 | Libbs Farmaceutica Ltda | pharmaceutical combination to treat and / or prevent fibroid and / or endometriosis, use of resveratrol and progestogen, pharmaceutical composition for treatment and / or prevention of fibroid and / or endometriosis drug for treatment and / or prevention of fibroid and / or endometriosis, kit and Method for the treatment and / or prevention of fibroid and / or endometriosis |
MX2014008693A (en) * | 2012-01-27 | 2014-08-27 | Agile Therapeutics Inc | Transdermal hormone delivery. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4210165A1 (en) * | 1991-07-30 | 1993-02-04 | Schering Ag | TRANSDERMAL THERAPEUTIC SYSTEMS |
DE4210711A1 (en) * | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS |
DE4227989A1 (en) * | 1992-08-21 | 1994-06-09 | Schering Ag | Agent for transdermal application containing 3-keto-desogestrel |
DE4229820C2 (en) * | 1992-09-07 | 1998-12-03 | Jenapharm Gmbh | Progestogen-based pharmaceutical preparation |
-
1994
- 1994-02-18 DE DE4405899A patent/DE4405899A1/en not_active Withdrawn
-
1995
- 1995-02-09 NZ NZ279226A patent/NZ279226A/en unknown
- 1995-02-09 HU HU9602286A patent/HUT74458A/en unknown
- 1995-02-09 CA CA002183544A patent/CA2183544A1/en not_active Abandoned
- 1995-02-09 JP JP7521560A patent/JPH09508911A/en active Pending
- 1995-02-09 KR KR1019960704500A patent/KR970701538A/en not_active Application Discontinuation
- 1995-02-09 AU AU15786/95A patent/AU1578695A/en not_active Abandoned
- 1995-02-09 EP EP95907661A patent/EP0744943A1/en not_active Withdrawn
- 1995-02-09 WO PCT/EP1995/000481 patent/WO1995022321A1/en not_active Application Discontinuation
-
1996
- 1996-08-16 NO NO963433A patent/NO963433L/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE4405899A1 (en) | 1995-08-24 |
HUT74458A (en) | 1996-12-30 |
KR970701538A (en) | 1997-04-12 |
NZ279226A (en) | 1998-05-27 |
HU9602286D0 (en) | 1996-10-28 |
EP0744943A1 (en) | 1996-12-04 |
JPH09508911A (en) | 1997-09-09 |
CA2183544A1 (en) | 1995-08-24 |
WO1995022321A1 (en) | 1995-08-24 |
NO963433L (en) | 1996-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2263295A (en) | Contrast agents | |
AU2907295A (en) | Ic-processed microneedles | |
AU3613695A (en) | Liposomal agents | |
AU9790198A (en) | Compounds and methods | |
AU2784397A (en) | Contrast agents | |
AU3308195A (en) | Antihypertriglyceridemic composition | |
AU4656596A (en) | Transdermal formulation | |
AU3701397A (en) | Anti-herpesviral agent | |
AU1466095A (en) | Dermatologic composition | |
AU3423195A (en) | New melatonergic agents | |
AU4774296A (en) | Transdermal formulation | |
AU1578695A (en) | Desogestrel-containing transdermal application agent | |
AU4914396A (en) | Transdermal formulation | |
AUPM690494A0 (en) | Attenuator | |
AU3554995A (en) | Antipicornaviral agents | |
AU6544294A (en) | Polystyrene-dissolving agent | |
AU2728295A (en) | Cat-food dressing | |
AU3052195A (en) | Hemopoietic function-stimulating agent | |
AU2154695A (en) | Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof | |
AU2813195A (en) | Composition | |
AU6369996A (en) | Anti-piroplasmotic agent | |
AU3194197A (en) | Stainblocking agent | |
AUPM756194A0 (en) | Transdermal composition | |
AUPO314896A0 (en) | Therapeutic agent | |
AU3215595A (en) | Antifungal agent |